IBI3002 for moderate to severe asthma
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You weigh at least 40 kg (about 88 pounds).
- You have had asthma for at least one year.
- You use a daily inhaler (with or without steroids) and your dose has been steady for at least one month.
- You have a breathing test showing your lung function is no more than 80% of normal for your age and height.
- You have high levels of inflammation markers: either a FeNO test of 25 or higher, or an eosinophil blood count of 300 or more (or 150 or more at screening).
- You have not had a life-threatening asthma attack in the last 5 years.
- You do not have active tuberculosis or other serious lung diseases like COPD.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
This study tests an investigational drug to see if it can improve asthma control in people whose asthma is not well managed with current treatments. It may help reduce symptoms and improve lung function.
This trial tests a new drug called IBI3002 in people with moderate-to-severe atopic dermatitis (eczema) to see if it is safe and tolerable. It may help reduce skin inflammation and itching.
This trial tests if adding immune-modulating tablets (Staphylococcus and Neisseria) to standard asthma medication (budesonide formoterol) helps control asthma better. It is for people whose asthma is not well controlled despite current treatment.
This trial tests an investigational drug called CM326 for people with moderate to severe asthma that is not well controlled with current treatments. It aims to see if CM326 can help reduce asthma attacks and improve breathing.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.